Bank of Montreal Can Lowers Position in Humana Inc. (NYSE:HUM)

Bank of Montreal Can decreased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 14.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 162,140 shares of the insurance provider's stock after selling 27,028 shares during the quarter. Bank of Montreal Can owned about 0.13% of Humana worth $41,137,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. HighTower Advisors LLC lifted its stake in Humana by 2.1% in the 3rd quarter. HighTower Advisors LLC now owns 8,992 shares of the insurance provider's stock valued at $2,852,000 after purchasing an additional 187 shares during the last quarter. MML Investors Services LLC raised its stake in Humana by 15.6% in the third quarter. MML Investors Services LLC now owns 4,737 shares of the insurance provider's stock valued at $1,500,000 after buying an additional 638 shares during the period. LRI Investments LLC lifted its position in shares of Humana by 1,021.4% in the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock valued at $50,000 after buying an additional 143 shares during the last quarter. Coldstream Capital Management Inc. boosted its stake in shares of Humana by 27.3% during the 3rd quarter. Coldstream Capital Management Inc. now owns 3,318 shares of the insurance provider's stock worth $1,032,000 after acquiring an additional 712 shares during the period. Finally, Toronto Dominion Bank increased its holdings in shares of Humana by 1.3% during the 3rd quarter. Toronto Dominion Bank now owns 59,992 shares of the insurance provider's stock worth $19,002,000 after acquiring an additional 754 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several equities research analysts have issued reports on HUM shares. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Guggenheim started coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price for the company. Piper Sandler increased their price target on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Morgan Stanley reduced their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Finally, Barclays upped their price target on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research note on Friday, April 11th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $284.90.

Humana Stock Performance

Shares of HUM stock traded up $3.38 on Wednesday, hitting $290.16. 231,076 shares of the stock were exchanged, compared to its average volume of 1,627,455. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The firm's 50 day moving average is $265.57 and its two-hundred day moving average is $270.22. The firm has a market capitalization of $35.02 billion, a PE ratio of 29.16, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is presently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.